跳转至内容
Merck
CN
  • [Complete remission of hepatocellular carcinoma with multiple lung metastases by oral administration of tegafur/uracil].

[Complete remission of hepatocellular carcinoma with multiple lung metastases by oral administration of tegafur/uracil].

Gan to kagaku ryoho. Cancer & chemotherapy (2013-08-30)
Kazutaka Tanabe, Kojiro Taura, Etsuro Hatano, Yukinori Koyama, Yasutsugu Takada, Shinji Uemoto
摘要

We report a case of multiple lung metastases from hepatocellular carcinoma(HCC)successfully treated by oral administration of tegafur/uracil(UFT). A 70-year-old man underwent left hepatic lobectomy for HCC. Intrahepatic recurrence appeared 3 months after the operation and multiple lung metastases appeared at 6 months. Transarterial chemoembolization and radiofrequency ablation were applied for intrahepatic recurrences, and oral administration of UFT(300 mg/day)was initiated for lung metastases. Four months after the initiation of UFT therapy, CT scan showed complete remission(CR)of liver and lung lesions, and elevated AFP and PIVKA-II levels returned to normal. Although the patient underwent a partial hepatectomy for solitary intrahepatic recurrence 2 years later, CR of lung metastases was maintained. The present case suggests the clinical usefulness of UFT for HCC with extrahepatic recurrences, given that effective systemic treatments for HCC are currently limited.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
尿嘧啶, ≥99.0%
Sigma-Aldrich
尿嘧啶, BioReagent, suitable for cell culture
氟尿嘧啶杂质C, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
尿嘧啶, Vetec, reagent grade, 98%